Literature DB >> 14610467

Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.

Tanuja Chitnis1, Samia J Khoury.   

Abstract

Multiple sclerosis is an immune-mediated disorder of the central nervous system. T lymphocytes are thought to play a central role in the initiation and potentially in the propagation of this disease. Two signals are required for T-cell activation. The first signal consists of the interaction of the T-cell receptor with antigen presented by the MHC molecule on antigen-presenting cells. The second signal requires engagement of costimulatory receptors on T cells with their ligands on antigen-presenting cells. Several costimulatory pathways have been shown to play an important role in T-lymphocyte activation. Here we will review the current literature on the contribution of the B7-1/2-CD28/CTLA-4, inducible costimulatory molecule-B7h, programmed death pathway 1-programmed death pathway ligand 1/ligand 2, CD40-CD154, OX40-OX40 ligand, and CD137-CD137 ligand pathways to the pathogenesis of multiple sclerosis and their potential roles as therapeutic targets.

Entities:  

Mesh:

Year:  2003        PMID: 14610467     DOI: 10.1016/j.jaci.2003.08.025

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  16 in total

Review 1.  Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.

Authors:  Debora Giunti; Benedetta Parodi; Christian Cordano; Antonio Uccelli; Nicole Kerlero de Rosbo
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

Review 2.  Th9 cells in the pathogenesis of EAE and multiple sclerosis.

Authors:  Wassim Elyaman; Samia J Khoury
Journal:  Semin Immunopathol       Date:  2016-11-14       Impact factor: 9.623

3.  Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models.

Authors:  Sarah Neil; Jaebong Huh; Victoria Baronas; Xinhui Li; Henry F McFarland; Murali Cherukuri; James B Mitchell; Jacqueline A Quandt
Journal:  Brain Behav Immun       Date:  2017-02-24       Impact factor: 7.217

Review 4.  Role of platelets in neuroinflammation: a wide-angle perspective.

Authors:  Lawrence L Horstman; Wenche Jy; Yeon S Ahn; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; J Steven Alexander; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2010-02-03       Impact factor: 8.322

5.  Characterization of human platelet binding of recombinant T cell receptor ligand.

Authors:  Asako Itakura; Joseph E Aslan; Sushmita Sinha; Tara C White-Adams; Ishan A Patel; Roberto Meza-Romero; Arthur A Vandenbark; Gregory G Burrows; Halina Offner; Owen Jt McCarty
Journal:  J Neuroinflammation       Date:  2010-11-08       Impact factor: 8.322

6.  Distinct functions of autoreactive memory and effector CD4+ T cells in experimental autoimmune encephalomyelitis.

Authors:  Wassim Elyaman; Pia Kivisäkk; Jay Reddy; Tanuja Chitnis; Khadir Raddassi; Jaime Imitola; Elizabeth Bradshaw; Vijay K Kuchroo; Hideo Yagita; Mohamed H Sayegh; Samia J Khoury
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

Review 7.  Translational utility of experimental autoimmune encephalomyelitis: recent developments.

Authors:  Andre Ortlieb Guerreiro-Cacais; Hannes Laaksonen; Sevasti Flytzani; Marie N'diaye; Tomas Olsson; Maja Jagodic
Journal:  J Inflamm Res       Date:  2015-11-13

8.  Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.

Authors:  Suzanne A B M Aarts; Tom T P Seijkens; Pascal J H Kusters; Susanne M A van der Pol; Barbara Zarzycka; Priscilla D A M Heijnen; Linda Beckers; Myrthe den Toom; Marion J J Gijbels; Louis Boon; Christian Weber; Helga E de Vries; Gerry A F Nicolaes; Christine D Dijkstra; Gijs Kooij; Esther Lutgens
Journal:  J Neuroinflammation       Date:  2017-05-12       Impact factor: 8.322

9.  Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function.

Authors:  Sheng Xiao; Nader Najafian; Jay Reddy; Monica Albin; Chen Zhu; Eric Jensen; Jaime Imitola; Thomas Korn; Ana C Anderson; Zheng Zhang; Cristina Gutierrez; Thomas Moll; Raymond A Sobel; Dale T Umetsu; Hideo Yagita; Hisaya Akiba; Terry Strom; Mohamed H Sayegh; Rosemarie H DeKruyff; Samia J Khoury; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2007-07-02       Impact factor: 14.307

10.  The effect of single course high dose dexamethasone on CD28/CTLA-4 balance in the treatment of patients with newly diagnosed primary immune thrombocytopenia.

Authors:  Xinhong Guo; Halida Yasen; Fang Zhao; Lei Wang; Mingling Sun; Nannan Pang; Xiujuan Wang; Ying Zhang; Jianbing Ding; Xiumin Ma
Journal:  Hum Vaccin Immunother       Date:  2015-07-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.